Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease

Lignende værker

• Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
  af: Jennifer Riley, et al.
  Udgivet: (2015-09-01)
• Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
  af: Moraes, Carolina B., et al.
  Udgivet: (2014)
• Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-Chagas agents
  af: Choi, Jun Yong, et al.
  Udgivet: (2013)
• Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
  af: Gunatilleke, Shamila S., et al.
  Udgivet: (2012)
• Antitrypanosomal lead discovery: Identification of a ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth
  af: Andriani, Grasiella, et al.
  Udgivet: (2013)